Cognitive function in aging cocaine smokers.


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 7 6 2019
medline: 29 7 2020
entrez: 7 6 2019
Statut: ppublish

Résumé

Little is known about the functional status of older drug users, who may pose challenges to public health systems in coming years. Here, we assessed cognitive function in aging cocaine smokers compared to demographically matched controls. A total of 22 non-treatment-seeking aging (50-60 years old) cocaine smokers (⩾twice/week; ⩾15 years of weekly use) and 19 controls completed a comprehensive cognitive battery. Controls with cannabis, tobacco, and alcohol use were included to better match the cocaine users. All cocaine users, and current cannabis- or alcohol-using controls, completed testing after 4 drug-free inpatient days to better control for acute and residual drug effects. Cocaine users (52.9 ± 2.5 years old, four female; cocaine use 3.9 ± 1.4 days/week) and controls (52.7 ± 2.6 years old, four female) were well matched demographically, but cocaine users reported a more extensive substance use profile. Cocaine users showed marginally worse verbal learning than controls, recalling on average one word fewer across immediate and delayed word recall trials. Their performance was intact relative to controls across all other measures of cognitive function. Bayesian analysis indicated the absence of group differences was not due to power limitations. These data suggest that aging, long-term cocaine users have similar cognitive functioning to appropriately matched controls when tested under drug-free conditions, with only marginal decreases in verbal learning. Findings, although reassuring with regard to broad cognitive capacities in aging cocaine smokers, suggest that future investigations of cognitive function in aging drug users are warranted.

Sections du résumé

BACKGROUND
Little is known about the functional status of older drug users, who may pose challenges to public health systems in coming years. Here, we assessed cognitive function in aging cocaine smokers compared to demographically matched controls.
METHODS
A total of 22 non-treatment-seeking aging (50-60 years old) cocaine smokers (⩾twice/week; ⩾15 years of weekly use) and 19 controls completed a comprehensive cognitive battery. Controls with cannabis, tobacco, and alcohol use were included to better match the cocaine users. All cocaine users, and current cannabis- or alcohol-using controls, completed testing after 4 drug-free inpatient days to better control for acute and residual drug effects.
RESULTS
Cocaine users (52.9 ± 2.5 years old, four female; cocaine use 3.9 ± 1.4 days/week) and controls (52.7 ± 2.6 years old, four female) were well matched demographically, but cocaine users reported a more extensive substance use profile. Cocaine users showed marginally worse verbal learning than controls, recalling on average one word fewer across immediate and delayed word recall trials. Their performance was intact relative to controls across all other measures of cognitive function. Bayesian analysis indicated the absence of group differences was not due to power limitations.
CONCLUSION
These data suggest that aging, long-term cocaine users have similar cognitive functioning to appropriately matched controls when tested under drug-free conditions, with only marginal decreases in verbal learning. Findings, although reassuring with regard to broad cognitive capacities in aging cocaine smokers, suggest that future investigations of cognitive function in aging drug users are warranted.

Identifiants

pubmed: 31169441
doi: 10.1177/0269881119849812
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-810

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH107763
Pays : United States

Commentaires et corrections

Type : ErratumIn

Auteurs

Thomas Chao (T)

1 Department of Psychology, The New School for Social Research, New York, NY, USA.
2 Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, NY, USA.

Margaret Haney (M)

2 Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, NY, USA.

Ziva D Cooper (ZD)

2 Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, NY, USA.

Nehal P Vadhan (NP)

3 Hofstra-Northwell School of Medicine and Feinstein Institute for Medical Research, New York, NY, USA.

Nicholas T Van Dam (NT)

4 School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia.

Jared Van Snellenberg (J)

2 Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York, NY, USA.
5 Department of Psychiatry, SUNY Stony Brook School of Medicine, New York, NY, USA.
6 Division of Translational Imaging, New York State Psychiatric Institute, New York, NY, USA.

Gillinder Bedi (G)

7 Centre for Youth Mental Health, University of Melbourne, and Orygen National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH